Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Joan Korth-Bradley"'
Autor:
Pavol Polák, Porin Peric, Ingrid Louw, Stefanie M. Gaylord, Theresa Williams, Jean-Claude Becker, Ron Pedersen, Joan Korth-Bradley, Bonnie Vlahos
Publikováno v:
European Journal of Rheumatology, Vol 6, Iss 1, Pp 23-28 (2019)
Externí odkaz:
https://doaj.org/article/76b1c75f567f43c2ae727eea527d45a8
Autor:
Robert J Moots, Ricardo M Xavier, Chi Chiu Mok, Mahboob U Rahman, Wen-Chan Tsai, Mustafa H Al-Maini, Karel Pavelka, Ehab Mahgoub, Sameer Kotak, Joan Korth-Bradley, Ron Pedersen, Linda Mele, Qi Shen, Bonnie Vlahos
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0179308 (2017)
[This corrects the article DOI: 10.1371/journal.pone.0175207.].
Externí odkaz:
https://doaj.org/article/ae31931fea8a46669c33dfddcbc80e96
Autor:
Robert J Moots, Ricardo M Xavier, Chi Chiu Mok, Mahboob U Rahman, Wen-Chan Tsai, Mustafa H Al-Maini, Karel Pavelka, Ehab Mahgoub, Sameer Kotak, Joan Korth-Bradley, Ron Pedersen, Linda Mele, Qi Shen, Bonnie Vlahos
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0175207 (2017)
OBJECTIVE:To assess the incidence of anti-drug antibodies (ADA) in patients with rheumatoid arthritis (RA) treated with the TNF inhibitors etanercept (ETN), adalimumab (ADL), or infliximab (IFX), and determine the potential relationship with trough d
Externí odkaz:
https://doaj.org/article/6af16e2d555b4839b6545a44c5ff9ea2
Publikováno v:
Clinical and Translational Science
A randomized, parallel‐dose study assessed the pharmacokinetics (PK) and pharmacodynamics (PD) of etanercept in 61 patients with rheumatoid arthritis (RA) who received doses from 10 mg once‐weekly to 50 mg twice‐weekly for 4 weeks. Empiric appl
Autor:
Frank, Shafer, Robert J, Charnigo, Anna, Plotka, James, Baumann, Yali, Liang, Joan, Korth-Bradley
Publikováno v:
Clinical pharmacology in drug development. 4(3)
An open-label, single-dose, randomized, two-period, cross-over study comparing the pharmacokinetics of factor VIII activity in plasma (C) after administration of a new presentation of moroctocog alfa containing 3,000 IU in a dual-chamber syringe and
Publikováno v:
Journal of clinical pharmacology. 54(5)
Safety, tolerability, and pharmacokinetics of tigecycline in 76 healthy Japanese subjects were determined in three randomized, double-blind, placebo-controlled studies. Subjects in an ascending single-dose study (n = 40) received 25-150 mg intravenou
Autor:
Huifen Faye, Wang, Feng, Qiu, Xiongfe, Wu, Juanzhi, Fang, Penelope, Crownover, Joan, Korth-Bradley, Seth, Schulman
Publikováno v:
Clinical pharmacology in drug development. 3(3)
This open-label, nonrandomized study was conducted to evaluate the steady-state pharmacokinetics of sirolimus in 24 stable Chinese renal transplant patients receiving daily oral maintenance doses of sirolimus (1-4 mg). Repeated trough and serial whol
Autor:
Joan Korth-Bradley
Publikováno v:
Encyclopedia of Clinical Pharmacy ISBN: 0824706080
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69ffd24bdaf19598c63adb1a45086e33
https://doi.org/10.3109/9780824706081.105
https://doi.org/10.3109/9780824706081.105
Publikováno v:
Journal of Clinical Pharmacology; Aug2004, Vol. 44 Issue 8, p873-880, 8p
Autor:
Honghui Zhou, Alain Patat, Virginia Parks, Mary Buckwalter, Deborah Metzger, Joan Korth-Bradley
Publikováno v:
Journal of Clinical Pharmacology; May2004, Vol. 44 Issue 5, p543-550, 8p